Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
CJC-1295 structure

CJC-1295

Growth Hormone
Phase 2 Research
45%
Low-Moderate Risk
2/5

Warnings

May affect blood glucose
Not FDA approved

Contraindications

PregnancyBreastfeedingActive CancerPituitary Tumors

Drug Interactions

InsulinCorticosteroids

Possible Side Effects

Water RetentionTinglingFlushingHeadache

Legal & Regulatory

FDA Status Research Only
WADA Status Prohibited in Sport
Prescription Not Required

Pregnancy

Category X - Contraindicated